Predictions
Nielsen Holdings
Start price
Target price
Perf. (%)
€12.10
19.09.20
19.09.20
-
04.11.21
04.11.21
15.43%
01.12.20
01.12.20
High dividend yield expected
Differentiated customer and product portfolio
Revenue decline/stagnation expected
Little innovation
Novavax Inc.
Start price
Target price
Perf. (%)
€91.29
19.09.20
19.09.20
-
04.11.21
04.11.21
16.11%
27.11.20
27.11.20
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Alphabet Inc. C
Start price
Target price
Perf. (%)
€61.25
19.09.20
19.09.20
-
04.11.21
04.11.21
110.20%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Immunomedics Inc.
Start price
Target price
Perf. (%)
€72.02
19.09.20
19.09.20
-
04.11.21
04.11.21
3.10%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€7.40
19.09.20
19.09.20
-
29.09.20
29.09.20
72.97%
29.09.20
29.09.20
High risks for its business
Sorrento Therapeutics Inc.
Start price
Target price
Perf. (%)
€8.00
19.09.20
19.09.20
-
04.11.21
04.11.21
-26.89%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Paypal Holdings Inc
Start price
Target price
Perf. (%)
€148.38
19.09.20
19.09.20
-
20.10.20
20.10.20
15.57%
20.10.20
20.10.20
Top 10 in its market
Future proof or reliable business model
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Paypal Holdings Inc
Start price
Target price
Perf. (%)
€148.38
19.09.20
19.09.20
-
20.10.20
20.10.20
15.57%
20.10.20
20.10.20
Top 10 in its market
Future proof or reliable business model
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Paypal Holdings Inc
Start price
Target price
Perf. (%)
€148.38
19.09.20
19.09.20
-
20.10.20
20.10.20
15.57%
20.10.20
20.10.20
Top 10 in its market
Future proof or reliable business model
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Apple Inc.
Start price
Target price
Perf. (%)
€90.01
19.09.20
19.09.20
-
20.10.20
20.10.20
10.23%
20.10.20
20.10.20
positive Cash Flow expected
Standard Investments for future growth
Valuable balance sheet
Normal challenges to pay loans and raise capital
Apple Inc.
Start price
Target price
Perf. (%)
€90.01
19.09.20
19.09.20
-
20.10.20
20.10.20
10.23%
20.10.20
20.10.20
positive Cash Flow expected
Standard Investments for future growth
Valuable balance sheet
Normal challenges to pay loans and raise capital
Apple Inc.
Start price
Target price
Perf. (%)
€90.01
19.09.20
19.09.20
-
20.10.20
20.10.20
10.23%
20.10.20
20.10.20
positive Cash Flow expected
Standard Investments for future growth
Valuable balance sheet
Normal challenges to pay loans and raise capital
Apple Inc.
Start price
Target price
Perf. (%)
€90.01
19.09.20
19.09.20
-
20.10.20
20.10.20
10.23%
20.10.20
20.10.20
positive Cash Flow expected
Standard Investments for future growth
Valuable balance sheet
Normal challenges to pay loans and raise capital
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€7.40
19.09.20
19.09.20
-
23.09.20
23.09.20
34.46%
23.09.20
23.09.20
Could be very worthwhile Investment >20% year
ConAgra Foods Inc.
Start price
Target price
Perf. (%)
€29.31
19.09.20
19.09.20
-
04.11.21
04.11.21
2.92%
20.11.20
20.11.20
EBIT growth >5% per year expected
Revenue growth >5% per year expected
High dividend yield expected
Apple Inc.
Start price
Target price
Perf. (%)
€91.07
18.09.20
18.09.20
-
04.11.21
04.11.21
21.05%
21.06.21
21.06.21
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Very high dividend yield expected
EBIT growth > 30% per year expected
Apple Inc.
Start price
Target price
Perf. (%)
€91.07
18.09.20
18.09.20
-
04.11.21
04.11.21
21.05%
21.06.21
21.06.21
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Very high dividend yield expected
EBIT growth > 30% per year expected
Apple Inc.
Start price
Target price
Perf. (%)
€91.07
18.09.20
18.09.20
-
04.11.21
04.11.21
21.05%
21.06.21
21.06.21
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Very high dividend yield expected
EBIT growth > 30% per year expected
Apple Inc.
Start price
Target price
Perf. (%)
€91.07
18.09.20
18.09.20
-
04.11.21
04.11.21
21.05%
21.06.21
21.06.21
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Very high dividend yield expected
EBIT growth > 30% per year expected
Commerzbank AG
Start price
Target price
Perf. (%)
€4.55
18.09.20
18.09.20
€7.00
19.09.20
19.09.20
-1.12%
19.09.20
19.09.20
Could be worthwhile Investment >10% per year
VERBIO Vereinigte BioEnergie AG
Start price
Target price
Perf. (%)
€16.98
17.09.20
17.09.20
€55.00
04.11.21
04.11.21
339.05%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
VERBIO Vereinigte BioEnergie AG
Start price
Target price
Perf. (%)
€16.98
17.09.20
17.09.20
€55.00
04.11.21
04.11.21
339.05%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group